Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study
接受新辅助和诱导治疗的局限性胰腺腺癌患者，接受FOLFIRINOX方案与吉西他滨-白蛋白紫杉醇方案治疗后的生存率比较：一项国际多中心研究
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-03025-1
Stoop, Thomas F; Wu, Y H Andrew; Oba, Atsushi; Ali, Mahsoem; Feld, Isabel M; Al-Musawi, Mohammed H; Jain, Ajay; Saiura, Akio; Sauvanet, Alain; Coppola, Alessandro; Javed, Ammar A; Groot Koerkamp, Bas; Miller, Braden N; Hashimoto, Daisuke; Caputo, Damiano; Kleive, Dyre; Sereni, Elisabetta; Kazemier, Geert; Belfiori, Giulio; Ishida, Hirofumi; van Dam, Jacob L; Dembinski, Jeanne; Akahoshi, Keiichi; Roberts, Keith J; Tanaka, Kimitaka; Labori, Knut J; Falconi, Massimo; House, Michael G; Sugimoto, Motokazu; Tanabe, Minoru; Gotohda, Naoto; Chatzizacharias, Nikolaos; Krohn, Paul S; Dokmak, Safi; Rodriguez Franco, Salvador; Hirano, Satoshi; Burgdorf, Stefan K; Crippa, Stefano; Satoi, Sohei; Nguyen, Trang K; Yamamoto, Tomohisa; Nakamura, Toru; Ushida, Yuta; Bachu, Vismaya; Burns, William R; Inoue, Yosuke; Takahashi, Yu; Aslami, Zohra; Schulick, Richard D; He, Jin; Messersmith, Wells; Besselink, Marc G; Burkhart, Richard A; Wilmink, Johanna W; Del Chiaro, Marco
